Chilean startup creates innovative kit to prevent cervical cancer

Chilean healthcare company GenoSUR is celebrating a new milestone in women’s health with the launch of SAFEM, a molecular biology-based vaginal self-sampling kit that allows women to prevent cervical cancer in the comfort of their home.

Known for its leadership role in the fight against COVID-19, GenoSUR has taken a significant step towards cervical cancer prevention with the launch of SAFEM. This innovative self-sampling kit, based on the latest molecular biology technologies, offers women a safe and effective tool for the early detection of women’s health-related infections, with an emphasis on identifying human papillomavirus (HPV).

During the pandemic, GenoSUR has established itself as a leader in the field of molecular biology, achieving notable achievements such as the creation of COVID-19 sampling kits and the development of the Nonaamp reagent for processing PCR samples in record time. Now, with SAFEM, the company is mobilizing its expertise to improve women’s health through remote diagnostics and vaginal self-sampling.

Advertising

According to the Ministry of Health, cervical cancer is the most common cancer in women aged 30 to 54 years in Chile, with about a thousand new cases reported each year. SAFEM, with its sensitivity and accuracy, can detect HPV and its oncogenic subtypes years before cancer develops, giving women the opportunity to take control of their intimate health.

SAFEM’s ease of use is notable: women can collect their own sample from home by purchasing a kit online and mailing the sample to the laboratory. Results are delivered via email for privacy and convenience. If necessary, it is recommended to make an appointment with a specialist doctor for individual advice.

With SAFEM, GenoSUR reaffirms its commitment to innovation and women’s health by promoting a preventive approach. The kit is available at (https://safem.genosur.com/inicio)(https://safem.genosur.com/inicio) and is intended for women of legal age who meet specific requirements to ensure accurate and reliable results.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button